University of California, San Diego

Total Page:16

File Type:pdf, Size:1020Kb

University of California, San Diego UC San Diego UC San Diego Electronic Theses and Dissertations Title Cell type specific gene expression : profiling and targeting Permalink https://escholarship.org/uc/item/36m3m5n3 Author Nathanson, Jason Lawrence Publication Date 2008 Peer reviewed|Thesis/dissertation eScholarship.org Powered by the California Digital Library University of California UNIVERSITY OF CALIFORNIA, SAN DIEGO Cell type specific gene expression: profiling and targeting A dissertation submitted in partial satisfaction of the requirements for the degree Doctor of Philosophy in Bioengineering by Jason Lawrence Nathanson Committee in charge: Professor Lanping Amy Sung, Chair Professor Edward M Callaway, Co-Chair Professor Fred H Gage Professor Vivian Hook Professor Xiaohua Huang Professor Gabriel A Silva 2008 Copyright Jason Nathanson, 2008 All rights reserved. The Dissertation of Jason Lawrence Nathanson is approved, and it is acceptable in quality and form for publication on microfilm and electronically: Co-chair Chair University of California, San Diego 2008 iii DEDICATION I dedicate this dissertation in recognition of the untiring support and encouragement from family and friends. I am especially grateful to my parents for their support and love from the beginning of my days, to my mom’s parents for their unwavering financial and inspirational support of my undergraduate and graduate school endeavors, to my dad’s parents for their love and hugs, to my brothers and sisters for their laughter and encouragement, and to Noah for his tolerance of my late hours and grouchy moods. My appreciation also goes to all my teachers and co-workers for their guidance, patience and goodwill. iv TABLE OF CONTENTS Signature Page…………………………………………………………….... iii Dedication…………………………………………………………………... iv Table of Contents…………………………………………………………… v List of Figures………………………………………………………………. viii List of Tables……………………………………………………………….. x Acknowledgements…………………………………………………………. xi Vita………………………………………………………………………….. xii Abstract of the Dissertation…………………………………………………. xiii Chapter 1 Cell type profiling of hippocampal neurogenesis using laser capture microdissection, DNA microarrays and anatomical-based clustering……… 1 Abstract……………………………………………………………… 2 Introduction…………………………………………………………. 3 Materials and Methods……………………………………………… 8 Results………………………………………………………………. 13 1.1 DNA microarrays successfully identified genes enriched in the inner portion of the GZ and a number of these genes corresponded to known cell types…………………………….... 13 1.2 Anatomical-based clustering grouped genes into basic cell types……………………………………………………….. 14 1.3 Over-expressed gene ontology classifications identified functional roles for groups of clustered genes…………………. 19 1.4 Some SGZ enriched genes also showed running-induced increases in gene expression…………………………………… 22 Conclusions……………………………………………………….… 23 Figures………………………………………………………………. 28 v Tables……………………………………………………………….. 49 Chapter 2 Selective transduction of inhibitory and excitatory cortical neurons by endogenous tropism of AAV and lentiviral vectors………………………... 52 Abstract……………………………………………………………... 53 Introduction…………………………………………………………. 54 Materials and Methods……………………………………………… 56 Results………………………………………………………………. 61 2.1 AAV biased expression to inhibitory neurons…………………. 62 2.2 AAV tropism showed titer dependency………………………... 63 2.3 LV predominately labeled excitatory neurons………………... 64 Conclusions…………………………………………………………. 67 Figures………………………………………………………………. 72 Tables………………………………………………………………... 77 Chapter 3 Short promoters drive inhibitory neuron class specific, but not subtype specific expression in the mammalian brain………………………………... 79 Abstract……………………………………………………………... 80 Introduction…………………………………………………………. 82 Materials and Methods……………………………………………… 87 Results………………………………………………………………. 97 3.1 Fugu promoters…………………………………………………. 97 3.1.1 Fugu promoters in AAV drove expression in mouse cortex………………………………………… 97 3.1.2 Fugu promoters in AAV drove expression in vi rat and monkey cortex………………………………. 99 3.1.3 Fugu promoters in AAV drove expression in dentate gyrus and thalamus…………………………. 99 3.1.4 AAV-fSST expression strongly favored cortical inhibitory neurons…………………………………… 100 3.1.5 Fugu promoters failed to generate inhibitory cell subtype specific expression…………………………. 101 3.1.6 Fugu promoter in lentivirus drove expression in excitatory neurons…………………………………... 102 3.2 Mammalian promoters…………………………………………. 103 3.3 Transcription factor binding site assembled promoters……….. 105 Conclusions………………………………………………………… 107 Figures……………………………………………………………… 113 Tables………………………………………………………………. 129 References………………………………………………………………….. 135 vii LIST OF FIGURES Chapter 1 Figure 1 The SGZ of the dentate gyrus consists of many different cell types…………………………………………………………. 28 Figure 2 Laser capture microdissection (LCM) isolated the inner and outer regions of the dentate gyrus………………………..……… 29 Figure 3 In situ hybridization verified SGZ enrichment for genes found in the microarray screen………………………….............. 30 Figure 4 Canonical cell type expression patterns suggested classifiers for anatomical-based clustering ………………………….…….. 35 Figure 5 Clustering of SGZ enriched genes revealed cell type groupings ………………………………………………………. 38 Figure 6 Genes in each cluster group showed similar, but not identical expression patterns………………………………….... 39 Chapter 2 Figure 1 Virus injections in GAD67-GFP mice………………………. 72 Figure 2 Differences in promoter, titer and virus type affect neuron transduction efficiencies……………………………………….. 73 Figure 3 Dilution of virus shifts rAAV2/1 transduction away from excitatory neurons……………………………………………… 74 Figure 4 mCAMK promoter expresses in inhibitory neurons in rAAV2/1……………………………………………………….. 75 Supplemental Figure S1 NeuN labeling identifies neurons in rAAV2/1-CAG-RFP sections………………………………….. 76 Chapter 3 Figure 1 Vector design………………………………………………... 113 Figure 2 Fugu promoters in AAV expressed in mouse cortex………... 114 Figure 3 AAV-fSST, AAV-fNPY and AAV-fCAMK expressed in rat and monkey cortex…………………………………………. 116 Figure 4 Fugu promoters in AAV expressed in mouse dentate gyrus (DG) and thalamus………………………………………. 117 Figure 5 AAV-fSST predominately labeled inhibitory neurons in mouse cortex…………………………………………………… 118 Figure 6 AAV-fSST expression co-labeled with CR, PV, SST and VIP antibodies…………………………………………………. 119 Figure 7 Percentage of virus label in inhibitory neuron subtypes…….. 121 Figure 8 Fugu promoters in LV drove expression in large numbers of excitatory neurons…………………………………………... 122 Figure 9 Mammalian promoters drove expression in the rodent brain.. 123 Figure 10 Mammalian conserved TFBS promoters drove expression in mouse brain…………………………………………………. 124 Figure 11 AAV-DR1 drove expression in only a few cells…………… 126 viii Figure 12 AAV-E1 drove strong expression in a scattered population of cells ………………………………………………………… 127 ix LIST OF TABLES Chapter 1 Table 1 Enriched gene ontology terms………………………………… 49 Table 2 SGZ enriched genes up-regulated with running………………. 50 Table 3 SGZ enriched genes down-regulated with running…………… 51 Chapter 2 Table 1 Genomic and infectious titers………………………………….. 77 Supplemental Table S1 Virus expression counts in GAD67-GFP mice.. 78 Chapter 3 Table 1 AAV and LV vectors…………………………………………… 129 Supplemental Table 1 Co-expressed genes in the G30 (VIP), G42 (PV) and GIN (SST) cell type populations………………… 131 Supplemental Table 2 TFBS enriched in the G30 (VIP) population of co-expressed genes…………………………………………… 132 Supplemental Table 3 TFBS enriched in the G42 (PV) population of co-expressed genes……………………………………………… 133 Supplemental Figure 4 TFBS enriched in the GIN (SST) population of co-expressed genes…………………………………………… 134 x ACKNOWLEDGMENTS I would like to acknowledge all of my committee members, professors and co- workers for their support and encouragement. I especially acknowledge Professor Edward Callaway for his guidance, support and trust, and for the friendly atmosphere he creates in his lab; Lanping Amy Sung for her encouragement and giving me a start in research; and Edward Lein, who has been a such a wonderful mentor and to whom I owe so many of the skills I have learned in graduate school. And surely, without the friendly support of the Gage and Callaway labs my work would not have been possible. Thank you. The work in Chapter 1 was done in a joint effort with Edward Lein, a postdoc in the lab of Fred Gage and Director of Neuroscience at the Allen Brain Institute. The work in Chapter 2 was done in the lab of Edward Callaway. The dissertation author was the primary investigator of this work. The work in Chapter 3 was done in the lab of Edward Callaway. The dissertation author was the primary investigator of this work. Roberto Jappelli contributed to the work with fugu promoters. Eric Scheeff contributed to the bioinformatics analysis in the work with mammalian promoters from co-expresssed genes. Each of the contributors to this work has granted permission to include their work in this dissertation. xi VITA 2001 Bachelor of Science, University of California, San Diego 2002 Master of Science, University of California, San Diego 2003-2005 Teaching Assistant, Department of Bioengineering, University of California, San Diego 2001-2008 Research Assistant, Salk Institute for Biological Studies 2008 Doctor of Philosophy, University of California, San Diego PUBLICATIONS Yao W, Nathanson J, Lian I, Gage FH, Sung LA. “Mouse erythrocyte tropomodulin in the brain reported by lacZ knocked-in downstream from the E1 promoter” Gene Expr Patterns.
Recommended publications
  • In Silico Prediction of High-Resolution Hi-C Interaction Matrices
    ARTICLE https://doi.org/10.1038/s41467-019-13423-8 OPEN In silico prediction of high-resolution Hi-C interaction matrices Shilu Zhang1, Deborah Chasman 1, Sara Knaack1 & Sushmita Roy1,2* The three-dimensional (3D) organization of the genome plays an important role in gene regulation bringing distal sequence elements in 3D proximity to genes hundreds of kilobases away. Hi-C is a powerful genome-wide technique to study 3D genome organization. Owing to 1234567890():,; experimental costs, high resolution Hi-C datasets are limited to a few cell lines. Computa- tional prediction of Hi-C counts can offer a scalable and inexpensive approach to examine 3D genome organization across multiple cellular contexts. Here we present HiC-Reg, an approach to predict contact counts from one-dimensional regulatory signals. HiC-Reg pre- dictions identify topologically associating domains and significant interactions that are enri- ched for CCCTC-binding factor (CTCF) bidirectional motifs and interactions identified from complementary sources. CTCF and chromatin marks, especially repressive and elongation marks, are most important for HiC-Reg’s predictive performance. Taken together, HiC-Reg provides a powerful framework to generate high-resolution profiles of contact counts that can be used to study individual locus level interactions and higher-order organizational units of the genome. 1 Wisconsin Institute for Discovery, 330 North Orchard Street, Madison, WI 53715, USA. 2 Department of Biostatistics and Medical Informatics, University of Wisconsin-Madison, Madison, WI 53715, USA. *email: [email protected] NATURE COMMUNICATIONS | (2019) 10:5449 | https://doi.org/10.1038/s41467-019-13423-8 | www.nature.com/naturecommunications 1 ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-13423-8 he three-dimensional (3D) organization of the genome has Results Temerged as an important component of the gene regulation HiC-Reg for predicting contact count using Random Forests.
    [Show full text]
  • New Approaches to Functional Process Discovery in HPV 16-Associated Cervical Cancer Cells by Gene Ontology
    Cancer Research and Treatment 2003;35(4):304-313 New Approaches to Functional Process Discovery in HPV 16-Associated Cervical Cancer Cells by Gene Ontology Yong-Wan Kim, Ph.D.1, Min-Je Suh, M.S.1, Jin-Sik Bae, M.S.1, Su Mi Bae, M.S.1, Joo Hee Yoon, M.D.2, Soo Young Hur, M.D.2, Jae Hoon Kim, M.D.2, Duck Young Ro, M.D.2, Joon Mo Lee, M.D.2, Sung Eun Namkoong, M.D.2, Chong Kook Kim, Ph.D.3 and Woong Shick Ahn, M.D.2 1Catholic Research Institutes of Medical Science, 2Department of Obstetrics and Gynecology, College of Medicine, The Catholic University of Korea, Seoul; 3College of Pharmacy, Seoul National University, Seoul, Korea Purpose: This study utilized both mRNA differential significant genes of unknown function affected by the display and the Gene Ontology (GO) analysis to char- HPV-16-derived pathway. The GO analysis suggested that acterize the multiple interactions of a number of genes the cervical cancer cells underwent repression of the with gene expression profiles involved in the HPV-16- cancer-specific cell adhesive properties. Also, genes induced cervical carcinogenesis. belonging to DNA metabolism, such as DNA repair and Materials and Methods: mRNA differential displays, replication, were strongly down-regulated, whereas sig- with HPV-16 positive cervical cancer cell line (SiHa), and nificant increases were shown in the protein degradation normal human keratinocyte cell line (HaCaT) as a con- and synthesis. trol, were used. Each human gene has several biological Conclusion: The GO analysis can overcome the com- functions in the Gene Ontology; therefore, several func- plexity of the gene expression profile of the HPV-16- tions of each gene were chosen to establish a powerful associated pathway, identify several cancer-specific cel- cervical carcinogenesis pathway.
    [Show full text]
  • Comprehensive Study of Nuclear Receptor DNA Binding Provides a Revised Framework for Understanding Receptor Specificity
    ARTICLE https://doi.org/10.1038/s41467-019-10264-3 OPEN Comprehensive study of nuclear receptor DNA binding provides a revised framework for understanding receptor specificity Ashley Penvose 1,2,4, Jessica L. Keenan 2,3,4, David Bray2,3, Vijendra Ramlall 1,2 & Trevor Siggers 1,2,3 The type II nuclear receptors (NRs) function as heterodimeric transcription factors with the retinoid X receptor (RXR) to regulate diverse biological processes in response to endogenous 1234567890():,; ligands and therapeutic drugs. DNA-binding specificity has been proposed as a primary mechanism for NR gene regulatory specificity. Here we use protein-binding microarrays (PBMs) to comprehensively analyze the DNA binding of 12 NR:RXRα dimers. We find more promiscuous NR-DNA binding than has been reported, challenging the view that NR binding specificity is defined by half-site spacing. We show that NRs bind DNA using two distinct modes, explaining widespread NR binding to half-sites in vivo. Finally, we show that the current models of NR specificity better reflect binding-site activity rather than binding-site affinity. Our rich dataset and revised NR binding models provide a framework for under- standing NR regulatory specificity and will facilitate more accurate analyses of genomic datasets. 1 Department of Biology, Boston University, Boston, MA 02215, USA. 2 Biological Design Center, Boston University, Boston, MA 02215, USA. 3 Bioinformatics Program, Boston University, Boston, MA 02215, USA. 4These authors contributed equally: Ashley Penvose, Jessica L. Keenan. Correspondence
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Screening of a Clinically and Biochemically Diagnosed SOD Patient Using Exome Sequencing: a Case Report with a Mutations/Variations Analysis Approach
    The Egyptian Journal of Medical Human Genetics (2016) 17, 131–136 HOSTED BY Ain Shams University The Egyptian Journal of Medical Human Genetics www.ejmhg.eg.net www.sciencedirect.com CASE REPORT Screening of a clinically and biochemically diagnosed SOD patient using exome sequencing: A case report with a mutations/variations analysis approach Mohamad-Reza Aghanoori a,b,1, Ghazaleh Mohammadzadeh Shahriary c,2, Mahdi Safarpour d,3, Ahmad Ebrahimi d,* a Department of Medical Genetics, Shiraz University of Medical Sciences, Shiraz, Iran b Research and Development Division, RoyaBioGene Co., Tehran, Iran c Department of Genetics, Shahid Chamran University of Ahvaz, Ahvaz, Iran d Cellular and Molecular Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran Received 12 May 2015; accepted 15 June 2015 Available online 22 July 2015 KEYWORDS Abstract Background: Sulfite oxidase deficiency (SOD) is a rare neurometabolic inherited disor- Sulfite oxidase deficiency; der causing severe delay in developmental stages and premature death. The disease follows an auto- Case report; somal recessive pattern of inheritance and causes deficiency in the activity of sulfite oxidase, an Exome sequencing enzyme that normally catalyzes conversion of sulfite to sulfate. Aim of the study: SOD is an underdiagnosed disorder and its diagnosis can be difficult in young infants as early clinical features and neuroimaging changes may imitate some common diseases. Since the prognosis of the disease is poor, using exome sequencing as a powerful and efficient strat- egy for identifying the genes underlying rare mendelian disorders can provide important knowledge about early diagnosis, disease mechanisms, biological pathways, and potential therapeutic targets.
    [Show full text]
  • Renal Cell Neoplasms Contain Shared Tumor Type–Specific Copy Number Variations
    The American Journal of Pathology, Vol. 180, No. 6, June 2012 Copyright © 2012 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved. http://dx.doi.org/10.1016/j.ajpath.2012.01.044 Tumorigenesis and Neoplastic Progression Renal Cell Neoplasms Contain Shared Tumor Type–Specific Copy Number Variations John M. Krill-Burger,* Maureen A. Lyons,*† The annual incidence of renal cell carcinoma (RCC) has Lori A. Kelly,*† Christin M. Sciulli,*† increased steadily in the United States for the past three Patricia Petrosko,*† Uma R. Chandran,†‡ decades, with approximately 58,000 new cases diag- 1,2 Michael D. Kubal,§ Sheldon I. Bastacky,*† nosed in 2010, representing 3% of all malignancies. Anil V. Parwani,*†‡ Rajiv Dhir,*†‡ and Treatment of RCC is complicated by the fact that it is not a single disease but composes multiple tumor types with William A. LaFramboise*†‡ different morphological characteristics, clinical courses, From the Departments of Pathology* and Biomedical and outcomes (ie, clear-cell carcinoma, 82% of RCC ‡ Informatics, University of Pittsburgh, Pittsburgh, Pennsylvania; cases; type 1 or 2 papillary tumors, 11% of RCC cases; † the University of Pittsburgh Cancer Institute, Pittsburgh, chromophobe tumors, 5% of RCC cases; and collecting § Pennsylvania; and Life Technologies, Carlsbad, California duct carcinoma, approximately 1% of RCC cases).2,3 Benign renal neoplasms are subdivided into papillary adenoma, renal oncocytoma, and metanephric ade- Copy number variant (CNV) analysis was performed on noma.2,3 Treatment of RCC often involves surgical resec- renal cell carcinoma (RCC) specimens (chromophobe, tion of a large renal tissue component or removal of the clear cell, oncocytoma, papillary type 1, and papillary entire affected kidney because of the relatively large size of type 2) using high-resolution arrays (1.85 million renal tumors on discovery and the availability of a life-sus- probes).
    [Show full text]
  • DR1 Antibody A
    Revision 1 C 0 2 - t DR1 Antibody a e r o t S Orders: 877-616-CELL (2355) [email protected] Support: 877-678-TECH (8324) 7 4 Web: [email protected] 4 www.cellsignal.com 6 # 3 Trask Lane Danvers Massachusetts 01923 USA For Research Use Only. Not For Use In Diagnostic Procedures. Applications: Reactivity: Sensitivity: MW (kDa): Source: UniProt ID: Entrez-Gene Id: WB, IP H M R Mk Endogenous 19 Rabbit Q01658 1810 Product Usage Information 7. Yeung, K.C. et al. (1994) Genes Dev 8, 2097-109. 8. Kim, T.K. et al. (1995) J Biol Chem 270, 10976-81. Application Dilution 9. Kamada, K. et al. (2001) Cell 106, 71-81. Western Blotting 1:1000 Immunoprecipitation 1:50 Storage Supplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg/ml BSA and 50% glycerol. Store at –20°C. Do not aliquot the antibody. Specificity / Sensitivity DR1 Antibody recognizes endogenous levels of total DR1 protein. Species Reactivity: Human, Mouse, Rat, Monkey Species predicted to react based on 100% sequence homology: D. melanogaster, Zebrafish, Dog, Pig Source / Purification Polyclonal antibodies are produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Gly112 of human DR1 protein. Antibodies are purified by protein A and peptide affinity chromatography. Background Down-regulator of transcription 1 (DR1), also known as negative cofactor 2-β (NC2-β), forms a heterodimer with DR1 associated protein 1 (DRAP1)/NC2-α and acts as a negative regulator of RNA polymerase II and III (RNAPII and III) transcription (1-5).
    [Show full text]
  • Construction of Subtype‑Specific Prognostic Gene Signatures for Early‑Stage Non‑Small Cell Lung Cancer Using Meta Feature Selection Methods
    2366 ONCOLOGY LETTERS 18: 2366-2375, 2019 Construction of subtype‑specific prognostic gene signatures for early‑stage non‑small cell lung cancer using meta feature selection methods CHUNSHUI LIU1*, LINLIN WANG2*, TIANJIAO WANG3 and SUYAN TIAN4 1Department of Hematology, The First Hospital of Jilin University, Changchun, Jilin 130021; 2Department of Ultrasound, China‑Japan Union Hospital of Jilin University, Changchun, Jilin 130033; 3The State Key Laboratory of Special Economic Animal Molecular Biology, Institute of Special Wild Economic Animal and Plant Science, Chinese Academy Agricultural Science, Changchun, Jilin 130133; 4Division of Clinical Research, The First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China Received September 17, 2018; Accepted June 5, 2019 DOI: 10.3892/ol.2019.10563 Abstract. Feature selection in the framework of meta-analyses surgical resection of the tumors (3). Postoperative adjuvant (meta feature selection), combines meta-analysis with a feature chemotherapy may improve the survival rate of patients selection process and thus allows meta-analysis feature selec- with a poor prognosis. However, it is not recommended for tion across multiple datasets. In the present study, a meta patients with stage IA NSCLC, whose five‑year survival rate feature selection procedure that fitted a multiple Cox regres- is approximately 70% (2). Therefore, using biomarkers to sion model to estimate the effect size of a gene in individual identify patients with NSCLC who may benefit from adjuvant studies and to identify the overall effect of the gene using a chemotherapy is of clinical importance. meta-analysis model was proposed. The method was used to A biomarker is a measurable indicator of a biological identify prognostic gene signatures for lung adenocarcinoma state or condition (4).
    [Show full text]
  • Anti-DR1 Antibody (ARG58552)
    Product datasheet [email protected] ARG58552 Package: 50 μl anti-DR1 antibody Store at: -20°C Summary Product Description Rabbit Polyclonal antibody recognizes DR1 Tested Reactivity Ms Predict Reactivity Hu, Rat, Cow, Dog, Gpig, Hrs, Pig, Rb, Zfsh Tested Application WB Host Rabbit Clonality Polyclonal Isotype IgG Target Name DR1 Antigen Species Human Immunogen Synthetic peptide of Human DR1. (within the following sequence: KKTISPEHVIQALESLGFGSYISEVKEVLQECKTVALKRRKASSRLENLG) Conjugation Un-conjugated Alternate Names Dr1l; NC2; TATA-binding protein-associated phosphoprotein; Protein Dr1; NC2-beta; 1700121L09Rik; NC2beta; Down-regulator of transcription 1; Negative cofactor 2-beta; NC2B; NCB2 Application Instructions Predict Reactivity Note Predicted homology based on immunogen sequence: Cow: 100%; Dog: 100%; Guinea Pig: 93%; Horse: 100%; Human: 100%; Pig: 100%; Rabbit: 100%; Rat: 100%; Zebrafish: 100% Application table Application Dilution WB 1 µg/ml Application Note * The dilutions indicate recommended starting dilutions and the optimal dilutions or concentrations should be determined by the scientist. Positive Control Mouse kidney Calculated Mw 19 kDa Properties Form Liquid Purification Affinity purified. Buffer PBS, 0.09% (w/v) Sodium azide and 2% Sucrose. Preservative 0.09% (w/v) Sodium azide Stabilizer 2% Sucrose Concentration Batch dependent: 0.5 - 1 mg/ml www.arigobio.com 1/2 Storage instruction For continuous use, store undiluted antibody at 2-8°C for up to a week. For long-term storage, aliquot and store at -20°C or below. Storage in frost free freezers is not recommended. Avoid repeated freeze/thaw cycles. Suggest spin the vial prior to opening. The antibody solution should be gently mixed before use. Note For laboratory research only, not for drug, diagnostic or other use.
    [Show full text]
  • Role and Regulation of the P53-Homolog P73 in the Transformation of Normal Human Fibroblasts
    Role and regulation of the p53-homolog p73 in the transformation of normal human fibroblasts Dissertation zur Erlangung des naturwissenschaftlichen Doktorgrades der Bayerischen Julius-Maximilians-Universität Würzburg vorgelegt von Lars Hofmann aus Aschaffenburg Würzburg 2007 Eingereicht am Mitglieder der Promotionskommission: Vorsitzender: Prof. Dr. Dr. Martin J. Müller Gutachter: Prof. Dr. Michael P. Schön Gutachter : Prof. Dr. Georg Krohne Tag des Promotionskolloquiums: Doktorurkunde ausgehändigt am Erklärung Hiermit erkläre ich, dass ich die vorliegende Arbeit selbständig angefertigt und keine anderen als die angegebenen Hilfsmittel und Quellen verwendet habe. Diese Arbeit wurde weder in gleicher noch in ähnlicher Form in einem anderen Prüfungsverfahren vorgelegt. Ich habe früher, außer den mit dem Zulassungsgesuch urkundlichen Graden, keine weiteren akademischen Grade erworben und zu erwerben gesucht. Würzburg, Lars Hofmann Content SUMMARY ................................................................................................................ IV ZUSAMMENFASSUNG ............................................................................................. V 1. INTRODUCTION ................................................................................................. 1 1.1. Molecular basics of cancer .......................................................................................... 1 1.2. Early research on tumorigenesis ................................................................................. 3 1.3. Developing
    [Show full text]
  • Comparative Transcriptomics of Primary Cells in Vertebrates
    Edinburgh Research Explorer Comparative transcriptomics of primary cells in vertebrates Citation for published version: Alam, T, Agrawal, S, Severin, J, Young, R, Andersson, R, Amer, E, Hasegawa, A, Lizio, M, Ramilowski, J, Abugessaisa, I, Ishizu, Y, Noma, S, Tarui, H, Taylor, MS, Lassmann, T, Itoh, M, Kasukawa, T, Kawaji, H, Marchionni, L, Sheng, G, Forrest, ARR, Khachigian, LM, Hayashizaki, Y, Carninci, P & De Hoon, M 2020, 'Comparative transcriptomics of primary cells in vertebrates', Genome Research. https://doi.org/10.1101/gr.255679.119 Digital Object Identifier (DOI): 10.1101/gr.255679.119 Link: Link to publication record in Edinburgh Research Explorer Document Version: Peer reviewed version Published In: Genome Research Publisher Rights Statement: is article, published inGenome Research, is avail-able under a Creative Commons License (Attribution 4.0 Internatio General rights Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s) and / or other copyright owners and it is a condition of accessing these publications that users recognise and abide by the legal requirements associated with these rights. Take down policy The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer content complies with UK legislation. If you believe that the public display of this file breaches copyright please contact [email protected] providing details, and we will remove access to the work immediately and investigate your claim. Download date: 30. Sep. 2021 1 1 Comparative transcriptomics of primary cells in vertebrates 2 Tanvir Alam1, Saumya Agrawal2, Jessica Severin2, Robert S. Young3,4, Robin Andersson5, Erik 3 Arner2, Akira Hasegawa2, Marina Lizio2, Jordan Ramilowski2, Imad Abugessaisa2, Yuri Ishizu6, 4 Shohei Noma2, Hiroshi Tarui7, Martin S.
    [Show full text]
  • Homotypic Clusters of Transcription Factor Binding Sites Are a Key Component of Human Promoters and Enhancers
    Downloaded from genome.cshlp.org on October 4, 2021 - Published by Cold Spring Harbor Laboratory Press Research Homotypic clusters of transcription factor binding sites are a key component of human promoters and enhancers Valer Gotea,1 Axel Visel,2,3 John M. Westlund,4 Marcelo A. Nobrega,4 Len A. Pennacchio,2,3 and Ivan Ovcharenko1,5 1National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, Maryland 20894, USA; 2Genomics Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA; 3United States Department of Energy Joint Genome Institute, Walnut Creek, California 94598, USA; 4Department of Human Genetics, University of Chicago, Chicago, Illinois 60637, USA Clustering of multiple transcription factor binding sites (TFBSs) for the same transcription factor (TF) is a common feature of cis-regulatory modules in invertebrate animals, but the occurrence of such homotypic clusters of TFBSs (HCTs) in the human genome has remained largely unknown. To explore whether HCTs are also common in human and other verte- brates, we used known binding motifs for vertebrate TFs and a hidden Markov model–based approach to detect HCTs in the human, mouse, chicken, and fugu genomes, and examined their association with cis-regulatory modules. We found that evolutionarily conserved HCTs occupy nearly 2% of the human genome, with experimental evidence for individual TFs supporting their binding to predicted HCTs. More than half of the promoters of human genes contain HCTs, with a dis- tribution around the transcription start site in agreement with the experimental data from the ENCODE project. In addition, almost half of the 487 experimentally validated developmental enhancers contain them as well—a number more than 25-fold larger than expected by chance.
    [Show full text]